Hepatocyte growth factor (HGF) was originally isolated as a mitogen for adult hepatocytes, but this cytokine is now regarded as a multi-functional factor. In the present study, we show that the mouse liver in the middle and/or late stage of the fetal lie expresses both HGF and c-met (it, receptor) messages. HGF and c-met mRNA are coexpressed not only in the adherent layers of fetal liver long-term cultures (FL-LT-) and adult bone marrow long-term cultures (BM-LTCs), but also in the stromal cell lines MS-5 and PA-6. Addition of human HGF (2 and 20 ng/mL) to the LTCs enhances (1) nonadherent cell counts (ninefold in FL-LTCs and sixfold in BM-LTCs), (2) nonadherent colony-forming unit-in culture EPATOCYTE growth factor (HGF), which was first isolated as a liver regenerating factor from the plasma of patients with fulminant hepatitis' and from rat platelets*, is a powerful mitogen for hepatocytes in the primary culture. HGF is a glycoprotein consisting of a heavy chain (60 kD), which has four kringle domains, and a light chain (32 kD) with a serine protease-like d~main."~ As with other growth factors, HGF acts by binding to cell surface receptors that are the products of the c-met proto-oncogene, tyrosine kinase?s6 Recent progress has shown that HGF is a multi-functional factor having broad-spectrum mitogenic a~t i v i t y~.~ and morphogenic activity'@'' identical to the scatter f a~t o r .~. '~ We have recently found that the promyelocytic leukemia cell line, HL-60, produces HGF.14.'5 Based on these findings, we postulated that HGF could be a hematopoietic regulatory factor.
dT30 (Takara-Shuzo, Kyoto, Japan) according to the protocol s u p plied by the manufacture. Five micrograms of each poly(A)+RNA denatured with glyoxal and dimethyl sulfoxide was electrophoresed on a 0.8% agarose gel and blotted onto a Biodyne membrane (PALL, New York). Prehybridization was performed on 50% formamide, 50 mmoVL sodium phosphate (pH 6.5). 5 X Denhardt's solution, 5 X standard saline citrate (SSC), 0.1% sodium dodecyl sulfate (SDS), and 100 pg/mL denatured salmon testis DNA at 42°C for 3 hours. Hybridization was performed with lo6 cpm/mL of each probe radiolabeled using the Multiprime DNA labeling system (Amersham, Arlington Heights, L) in prehybridization solution. After hybridization overnight at 4 2 T , the filters were washed to a final stringency with 0.2X SSC and 0.1% SDS at 60°C. then autoradiographed with Kodak XAR film (Eastman Kodak, Rochester, NY).
Probes. Rat HGF cDNA" was cloned from the cDNA library of rat regenerating liver, and a 1.4-kb EcoRI fragment was used as a probe. Murine ~-met'~(nucleotide residues 1231-3091). stem cell facto9' (SCF; nucleotide residues 101-1013), c-kitZ2(nucleotide residues 218-1313), and p-actin' (nucleotide residues 309-1 161) cDNA fragments were prepared from poly(A)+ RNA of newborn mouse liver by reverse transcription polymerase-chain reaction (PCR) amplification. The c-met cDNA fragments were a generous gift from N. Kitamura (Kansai Medical University, Osaka, Japan). Five micrograms poly (A)+ RNA of the liver was reverse-transcripted using the ZAP cDNA synthesis kit (Stratagene, La Jolla, CA), and the cDNA product was used as a template for FCR in a reaction mix containing appropriate 5' and 3' primers for each. The cycle parameters were in all cases 94°C. 1 minute; 60°C. 1 minute; 72°C 1 minute (30 cycles). Each cDNA fragment was suhcloned into pT7BlueT vector (Novagen, Madison, WI) to determine its DNA sequence. cDNA inserts purified from the cloning vector were labeled by I2P using the Multiprime DNA labeling system (Amersham).
FL-LTCs. The fetal liver was removed from IS-day-old fetuses under aseptic conditions, pooled (about 10 organs) and put into a minimum essential medium (aMEM; GIBCO, Grand Island, NY). Cell suspensions of the liver were prepared by mincing the tissues and repeatedly flushing the fragments through 18-and 22-gauge needles. The cells were washed three times by centrifugation ( 5 0 0~ for 5 minutes). Cell suspensions were diluted in aMEM containing 10% horse serum (Nikken Biological Medicine Laboratory No. NDH-I 128). lO"mol/L hydrocortisone, 5 X IO-'mol/L 2-mercaptoethanol (2-ME). Liver cells (IO') were cultured in 8 mL of the medium, with or without HGF, using a 25-m2 bottle. The cultures were maintained at 37°C in a humidified atmosphere of 5% CO2 in air. After 4 days, the total medium containing nonadherent cells was discarded. Culture flasks (quadruplicates) were supplemented with 2 or 20 ng/mL human HGF, or no HGF. At 4-day intervals, the nonadherent cells in the half-culture supernatants were counted with trypan blue, and the medium was replaced by fresh medium. The nonadherent cells were then plated for the progenitor cell assay colony-forming unit-in culture (CFU-C), and morphogic analyses were performed on cytospin preparations stained with May Giemsa. Foci of hematopoiesis cells in the cultures were counted with an inverted-phase microscope. Scoring was facilitated through the use of a scored grid.
BM-LTCs. Mice were decapitated, and the femurs and tibias then dissected. The BM was flushed out into a flask using a sterile syringe containing aMEM with a 23-gauge needle, then repeatedly flushed through 18-gauge needles. BM-LTCs were performed according to modifications of the Dexter's method. 24 Bone marrow cells of one tibia and one femur from one mouse were cultured in 8 mL of aMEM in the same manner as the FL-LTCs. One week later, the total medium containing nonadherent cells was discarded, and each flask was recharged with fresh BM cells (2 X IO'), which were passed through a Sephadex G-10 (Pharmacia Fine Chemicals, Uppsala, Sweden) column to remove adherent cells. Culture flasks (quadruplicates) were then supplemented with 0, 2, or 20 ng/mL HGF. The schedule for the supplementation and removal of the medium and for each assay was the same as for the FL-LTCs.
Stromal cell lines. The cell lines used in this study were MS-S*' (C3H BM-derived preadipocytes) and PA-626 (C57BU6 newborn calvaria-derived preadipocytes). Both cell lines were cultured in aMEM, as described. When the cells became confluent in 225-cm2 flasks, they were washed with PBS (without Ca" and Mg"), then subjected to RNA extraction. In another experiment, when the cells became subconfluent in 2S-cm2 flasks, each flask was recharged with fresh BM cells (2 X IO5) passed through a Sephadex G-IO. Culture flasks (quadruplicate) were then either supplemented with HGF or not. The schedule for the supplementation and removal of the medium and for each assay was the same as for the FL-LTCs. CFU-C assay. Nonadherent cells obtained from either the longterm cultures or BM cell-charged stromal cell cultures were cultured for 7 days in 35-mm tissue culture dishes at 2 X IO4 cellslmL in I mL aMEM containing 0.8% methylcellulose, 5 X IO" mol/L 2-ME, 20% fetal calf serum (FCS), and 10% medium conditioned by lung and abdominal wall tissue. Experiments were also performed to examine the direct effects of HGF on the freshly isolated BM and fetal (15 day) liver cells. Cells were cultured with HGF alone or in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) or interleukin-3 (IL-3). essential medium containing 10% FCS. Recombinant human HGF in the supernatant was purified with fast protein liquid chromatography (FPLC) of S-Sepharose (Pharmacia) and Heparin Sepharose (Pharmacia), as previously described.' Mouse GM-CSF and IL-3 were purchased from Genzyme Corp (Boston, MA).
RESULTS
Expression of HGF and c-met mRNA in mouse fetal liver. We investigated the expression of HGF, c-met, SCF, and ckit mRNA in the mouse fetal andor newborn liver. In all specimens, HGF (6.0-kb) and c-met (7.0-kb) mRNA were expressed; on gestation day 18, both levels were markedly enhanced ( Fig I) . Although by IO weeks after birth the level of HGF mRNA had returned to the same level as on gestation day 12, the c-met mRNA level continued to increase. SCF (7.5-kb) and c-kit (5.0-kb) mRNAs were strongly expressed on gestation day 12. On gestation days 15 through 18, SCF and c-kit messages sharply decreased, whereas HGF and cmet expression dramatically increased. These data suggest that HGF in the fetal liver supervises both hematopoiesis and liver development.
For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From Expression of HGF and c-met mRNA in stromal layer of FL-or BM-LTCs and stromal cell lines. It is well known that the HGF message is expressed in fibroblasts, endothelial cells, and epithelial cells. To know whether stromal cells produce HGF as an autocrine or paracrine regulatory factor, we examined the expression of HGF and c-met mRNA in the adherent layers (stromal layer) of FL-or BM-LTCs and stromal cell lines, MS-5 and PA-6 (Fig 2) . HGF, c-met, SCF, and c-kit mRNA were detected in the stromal layer of FLLTCs (culture days 14 and 21). In the BM-LTCs, HGF and c-met messages were also detected. but not when hydrocortisone was added to the medium. In the BM-LTCs, the expression of both SCF and c-kit was very weak. MS-5 strongly expressed the messages of HGF, c-met, and SCF, but not ckit. In the case of PA-6, the expression of the HGF message was weak.
Effects of exogenous HGF on hematopoiesis in FL-or BM-LTCs and in culture of BMCs with MS-5. The effects of exogenous HGF on CFU-C counts and adherent colonies (adherent foci) in the stromal layer were examined in the FL-or BM-LTCs.
In the FL-LTCs, active production of nonadherent cells into the medium continued for about 40 days (Fig 3A) . An approximately ninefold increase in cell counts was noted on 3095 days 12 through 32 when 20 ng/mL HGF was added to the culture. When 2 ng/mL of HGF was added to the culture, an approximately threefold increase was observed. In the BM-LTCs, active production of nonadherent cells into the medium continued for more than 70 days (Fig 3B) . The addition of HGF to the culture reduced the number of days required to reach the maximum production of nonadherent cells: day 50 in the control, day 42 with 2 ng/mL of HGF, and day 34 with 20 ng/mL of HGF. An approximately sixfold increase in cell counts was noted on culture day 34 when 20 ng/mL HGF was added to the culture. When 2 ng/mL was added, an approximately twofold increase was noted on culture day 42. The addition of HGF to MS-5 cells enhanced the production of nonadherent cells (Fig 3C) .
Cytological studies showed that nonadherent cells cultured with HGF in the BM-LTCs include cells of all lineages, such as erythrocytes, macrophages, granulocytes and megakaryocytes (Fig 4) .
In the FL-LTCs, an approximately eightfold increase in CFU-C counts was noted in the culture when 20 ng/mL HGF was added. When 2 ng/mL HGF was added, an approximately threefold increase in CFU-C counts was noted ( Fig  5A) . In the BM-LTCs, an approximately fivefold increase in CFU-C counts was noted on culture day 34 when 20 ng/ mL HGF was added. When 2 ng/mL HGF was added, there was no significant difference (Fig 5B) . The addition of HGF to the MS-5 cells enhanced the CFU-C counts (Fig 5C) .
The increases in nonadherent cell and CFU-C counts suggest an increase in progenitor cell counts. Indeed, after about 2 weeks, the number of adherent foci increased in the stromal cell layers of the FL-and BM-LTCs. In the FL-LTCs, when HGF was added to the culture, more adherent foci were observed (Fig 6A) . In the BM-LTCs (Fig 6B) , the number of adherent foci reached a maximum on day 50 of culture. The number of adherent foci in the flasks in the presence of HGF increased in a dose-dependent manner. In addition to an increase in their number, the foci were also larger than in the control culture (data not shown).
Direct effects of HGF on FL or BM cells. HGF had no direct effect on freshly isolated BM and/or FL cells in the CFU-C assay. No synergistic effect was observed when cells were cultured with a combination of HGF (2, 20, and 1 0 0 ng/mL) with mouse GM-CSF (1 through IO ng/mL). An =1.5-fold synergistic increase in CFU-C counts was noted when the FL or BM cells were cultured with IL-3 in the presence of HGF (100 ng/mL), in contrast with IL-3 alone (Fig 7) .
Effects of HGF on proliferation of stromal cell lines. To determine whether HGF stimulates the proliferation of hematopoietic stromal cells as a growth factor, we examined the effects of HGF on the DNA synthesis of MS-5 and PA-6. HGF slightly inhibited the proliferation of MS-5 and PA-6 (Fig 8) . This finding suggests that HGF acts as a hematopoietic regulator rather than as a growth factor; HGF enhances the growth of hematopoietic progenitors, whereas it inhibits the proliferation of stromal cells, which can support progenitors.
DISCUSSION
In the present study, we have shown that HGF regulates hematopoiesis in the mouse fetal liver and adult BM. HGF Error bars indicate standard deviation. * P < .05, ** P < .Ol by Student's t-test (two tailed) versus lane 1.
and c-met mRNA were expressed in the mouse fetal liver at l), we have found that the c-met mRNA is expressed in the the middle and late stage when hematopoiesis is most active.
mouse fetal liver as early as gestation day 12. SCF and cAlthough there have been a number of reports regarding the kit mRNA were also expressed in the fetal liver on gestation expression of HGF andlor c-met in the human" and rat18 day 12, but both decreased sharply by gestation day 15, even fetal liver, the role of HGF in hematopoiesis remains to be though, at this stage, hematopoietic activity continues. In clarified. Although the HGF mRNA expression is low (Fig  contrast, HGF and c-met mRNA increased markedly, and For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From 
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only HGF mRNA returned to the previous level in the adult liver. These data suggest that the HGF-c-met system in the fetal liver regulates not only liver development, but also hematopoiesis. Kagoshima et a l Z 7 reported that HGF and cmet mRNA levels in the rat liver were very low during the late gestation or early neonatal periods, but increased postnatally. Hu et a l l 8 showed that low levels of HGF/c-met mRNA were expressed in the rat fetal liver, and that elevated levels of these transcripts were observed between 4 and 21 days after birth. There are thus some differences between mice and rats. Although the cause of these differences is uncertain, they can most likely be ascribed to the difference in species. Stromal layers of the FL-or BM-LTCs appear to express both HGF and c-met mRNA because hematopoietic progenitor cells adhering to the stromal layer in the LTCs could be washed out with a large volume of fresh medium. We also confirmed from microscopic observation that most cells in the adherent layer, which dispersed with EDTA-trypsin, were stromal cells. Actually, the stromal cell lines (MS-5 and PA-6) expressed both HGF and c-met mRNA (Fig 2) . These data suggest that HGF is produced by the stromal cells as an autocrine regulatory factor. Some reports indicate that HGF and c-met mRNA are coexpressed in cells such as human bronchial-epithelial cells2' and lung cancer cells.29 a report using murine BM cells by Kmiecik et al.30 Because the effect was manifested only with a relatively high dose (100 ng /mL), the phenomenon may not be essential to hematopoiesis. Because HGF and c-met were expressed strongly in the fetal liver, which is almost entirely devoted to erythropoiesi~,''-~~ the HGF/c-met system may aid erythropoiesis in the hematopoietic microenvironment. The second question is whether HGF promotes the growth of stromal cells. If HGF enhances the number of stromal cells in the adherent layer, the number of progenitor cells should increase. Basic fibroblast growth factor (bFGF) is a mitogen for human BM stromal cells,36 and stimulates myelopoiesis in the primary BM culture." Furthermore, it is expressed in the BM stromal cells." bFGF also augments the proliferation of progenitor cells when added with SCF39 or other growth factor^.^^.^' To clarify whether HGF contributes to the proliferation of hematopoietic stromal cells as a growth factor, we studied the effects of HGF on the DNA synthesis of stromal cell lines (MS-5 and PA-6) that express HGF and c-met. HGF slightly inhibited the incorporation of 'H-TdR to DNA of these stromal cell lines. Therefore, it appears that HGF regulates some stromal cell functions rather than promotes their growth. Enhanced hematopoiesis can be explained as follows: (1) The hematopoiesis augmented by HGF results from an increase or decrease in endogenous cytokines (SCF, IL-l, G-CSF, GM-CSF, IL-6, transforming growth factor P [TGFP] , etc) produced by the stromal cells. We are now investigating the secretory responses of various cytokines from the stromal cells by HGF. Finally, the HGF and c-met system may play a crucial role in the renewal and differentiation of stem cells, as proposed in the SCF and c-kit sy~tem."''~' Actually, SCF and c-kit, which are expressed in the fetal liver, decreased sharply at gestation day 15, even though hematopoiesis remained active. Instead, HGF and c-met mRNA expressions markedly increased. The LTCs using the BM of SVSld mice, which exhibit severe hematopoietic deficiencies due to an abnormality in the SCF showed that hematopoiesis recovered to wild-type (+/+) levels when a low dose of exogenous HGF was present in the culture medium (Li Y, Hisha H, Nishino T, Adachi M, Ikehara S: manuscript in preparation).
In the present study, we have shown that HGF and its receptor are expressed in the hematopoietic environments, and that exogenous HGF enhances hematopoiesis in the FLor BM-LTC. This suggests that the HGF and c-met system plays an important role in the growth and maintenance of hematopoietic progenitors (including stem cells) in the fetal and adult hematopoietic microenvironments. 
